Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML

In relapsed/refractory acute myeloid leukemia (AML), the prognostic impact of complete remission (CR) and measurable residual disease (MRD) negativity is not well established. We retrospectively analyzed 141 patients with relapsed/refractory AML who received first salvage therapy and had MRD assesse...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Short, Nicholas J., Rafei, Hind, Daver, Naval, Hwang, Hyunsoo, Ning, Jing, Jorgensen, Jeffrey L., Kadia, Tapan M., DiNardo, Courtney D., Wang, Sa A., Jabbour, Elias, Popat, Uday, Oran, Betul, Cortes, Jorge, Konopleva, Marina, Yilmaz, Musa, Issa, Ghayas C., Kantarjian, Hagop, Ravandi, Farhad
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7757010/
https://ncbi.nlm.nih.gov/pubmed/33351107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002811
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados